Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $15 Million - $16.5 Million
80,000 New
80,000 $15.4 Million
Q4 2022

Feb 14, 2023

BUY
$117.37 - $139.17 $105,633 - $125,252
900 Added 2.59%
35,600 $4.57 Million
Q3 2022

Nov 14, 2022

SELL
$135.27 - $180.11 $1.14 Million - $1.51 Million
-8,400 Reduced 19.49%
34,700 $4.75 Million
Q2 2022

Aug 15, 2022

BUY
$108.81 - $179.33 $4.69 Million - $7.73 Million
43,100 New
43,100 $7.63 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.